Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments

doi:10.1200/JCO.2014.55.8999

Comment

. 2014 Aug 10;32(23):2512-3.

doi: 10.1200/JCO.2014.55.8999. Epub 2014 Jul 7.

Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments

Affiliations

¹ AIDS Malignancy Consortium, New York, NY krowns@mskcc.org.
² University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
³ University of Colorado, Aurora, CO.
⁴ Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.
⁵ Lineberger Comprehensive Cancer Center and University of North Carolina at Chapel Hill, Chapel Hill, NC.
⁶ University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
⁷ Center for Clinical AIDS Research and Education, University of California, Los Angeles, Los Angeles, CA.
⁸ Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
⁹ Uganda Cancer Institute, Mulago Hospital, and Makarere College of Health Sciences, Kampala, Uganda.
¹⁰ University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Uganda Cancer Institute/Hutchinson Cancer Center Alliance, Kampala, Uganda.

PMID: 25002726
PMCID: PMC4809749
DOI: 10.1200/JCO.2014.55.8999

Comment

Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments

Susan E Krown et al. J Clin Oncol. 2014.

. 2014 Aug 10;32(23):2512-3.

doi: 10.1200/JCO.2014.55.8999. Epub 2014 Jul 7.

Authors

Affiliations

¹ AIDS Malignancy Consortium, New York, NY krowns@mskcc.org.
² University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
³ University of Colorado, Aurora, CO.
⁴ Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.
⁵ Lineberger Comprehensive Cancer Center and University of North Carolina at Chapel Hill, Chapel Hill, NC.
⁶ University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
⁷ Center for Clinical AIDS Research and Education, University of California, Los Angeles, Los Angeles, CA.
⁸ Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
⁹ Uganda Cancer Institute, Mulago Hospital, and Makarere College of Health Sciences, Kampala, Uganda.
¹⁰ University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Uganda Cancer Institute/Hutchinson Cancer Center Alliance, Kampala, Uganda.

PMID: 25002726
PMCID: PMC4809749
DOI: 10.1200/JCO.2014.55.8999

No abstract available

PubMed Disclaimer

Comment in

Reply to S.E. Krown et al.
Krell J, Stebbing J. Krell J, et al. J Clin Oncol. 2014 Aug 10;32(23):2514-5. doi: 10.1200/JCO.2014.56.3841. Epub 2014 Jul 7. J Clin Oncol. 2014. PMID: 25002718 No abstract available.
Reply to S.E. Krown et al.
Akindele L, Bower M. Akindele L, et al. J Clin Oncol. 2014 Aug 10;32(23):2513-4. doi: 10.1200/JCO.2014.56.3833. Epub 2014 Jul 7. J Clin Oncol. 2014. PMID: 25002719 No abstract available.

Comment on

Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma.
Krell J, Stebbing J. Krell J, et al. J Clin Oncol. 2014 Feb 10;32(5):373-5. doi: 10.1200/JCO.2013.53.7126. Epub 2013 Dec 30. J Clin Oncol. 2014. PMID: 24378412 No abstract available.
Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.
Bower M, Dalla Pria A, Coyle C, Andrews E, Tittle V, Dhoot S, Nelson M. Bower M, et al. J Clin Oncol. 2014 Feb 10;32(5):409-14. doi: 10.1200/JCO.2013.51.6757. Epub 2013 Dec 30. J Clin Oncol. 2014. PMID: 24378415

Cited by

Effectiveness and Safety of Treatment with Neodymium:YAG Laser 1064 nm in Patients with Classic and Epidemic Kaposi Sarcoma.
Silvestri M, Latini A, Lesnoni La Parola I, Messina C, Nisticò SP, Cameli N. Silvestri M, et al. Bioengineering (Basel). 2022 Mar 5;9(3):106. doi: 10.3390/bioengineering9030106. Bioengineering (Basel). 2022. PMID: 35324795 Free PMC article.
A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Moorad R, Kasonkanji E, Gumulira J, Gondwe Y, Dewey M, Pan Y, Peng A, Pluta LJ, Kudowa E, Nyasosela R, Tomoka T, Tweya H, Heller T, Gugsa S, Phiri S, Moore DT, Damania B, Painschab M, Hosseinipour MC, Dittmer DP. Moorad R, et al. Int J Cancer. 2023 Dec 15;153(12):2082-2092. doi: 10.1002/ijc.34689. Epub 2023 Aug 21. Int J Cancer. 2023. PMID: 37602960 Free PMC article.
Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.
Dittmer DP, Damania B. Dittmer DP, et al. J Clin Invest. 2016 Sep 1;126(9):3165-75. doi: 10.1172/JCI84418. Epub 2016 Sep 1. J Clin Invest. 2016. PMID: 27584730 Free PMC article. Review.
Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.
Bender Ignacio RA, Lee JY, Rudek MA, Dittmer DP, Ambinder RF, Krown SE; AIDS Malignancy Consortium (AMC)-059 Study Team. Bender Ignacio RA, et al. J Acquir Immune Defic Syndr. 2016 May 1;72(1):52-7. doi: 10.1097/QAI.0000000000000918. J Acquir Immune Defic Syndr. 2016. PMID: 26689971 Free PMC article. Clinical Trial.
Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series.
Russo I, Marino D, Cozzolino C, Del Fiore P, Nerjaku F, Finotto S, Cattelan A, Calabrò ML, Belloni Fortina A, Russano F, Mazza M, Galuppo S, Bezzon E, Sbaraglia M, Krengli M, Brunello A, Mocellin S, Piaserico S, Alaibac M. Russo I, et al. Cancers (Basel). 2024 Feb 6;16(4):691. doi: 10.3390/cancers16040691. Cancers (Basel). 2024. PMID: 38398082 Free PMC article.

See all "Cited by" articles

References

1. Bower M, Dalla Pria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014;32:409–414. - PubMed
1. Krell J, Stebbing J. Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014;32:373–375. - PubMed
1. Borok M, Fiorillo S, Gudza I, et al. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe. Clin Infect Dis. 2010;51:342–349. - PubMed
1. Mosam A, Shaik F, Uldrick TS, et al. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr. 2012;60:150–157. - PMC - PubMed
1. Gantt S, Kakuru A, Wald A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer. 2010;54:670–674. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

P30 AI050410/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Bower M, Dalla Pria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014;32:409–414. - PubMed

[2] Bower M, Dalla Pria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014;32:409–414. - PubMed

[3] Krell J, Stebbing J. Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014;32:373–375. - PubMed

[4] Krell J, Stebbing J. Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014;32:373–375. - PubMed

[5] Borok M, Fiorillo S, Gudza I, et al. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe. Clin Infect Dis. 2010;51:342–349. - PubMed

[6] Borok M, Fiorillo S, Gudza I, et al. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe. Clin Infect Dis. 2010;51:342–349. - PubMed

[7] Mosam A, Shaik F, Uldrick TS, et al. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr. 2012;60:150–157. - PMC - PubMed

[8] Mosam A, Shaik F, Uldrick TS, et al. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr. 2012;60:150–157. - PMC - PubMed

[9] Gantt S, Kakuru A, Wald A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer. 2010;54:670–674. - PMC - PubMed

[10] Gantt S, Kakuru A, Wald A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer. 2010;54:670–674. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments

Affiliations

Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical